Lv1
20 积分 2025-10-26 加入
Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia
2个月前
已完结
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial
2个月前
已完结
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2个月前
已完结
Stoppingversuscontinuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
2个月前
已完结
Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first‐in‐human and first‐in‐patient trials
2个月前
已完结
REGN1908/1909 prevented cat allergen–induced early asthmatic responses in an environmental exposure unit
2个月前
已完结
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2个月前
已完结
Comparative safety of monoclonal antibodies in chronic inflammatory airway diseases (chronic sinusitis with nasal polyposis and asthma): A network meta-analysis
5个月前
已完结
Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis
5个月前
已完结
Adverse effects of monoclonal antibodies in the treatment of moderate-to-severe asthma: a narrative review
5个月前
已完结
皖公网安备34019202002308
